0001485003-18-000044.txt : 20180411 0001485003-18-000044.hdr.sgml : 20180411 20180411165843 ACCESSION NUMBER: 0001485003-18-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180409 FILED AS OF DATE: 20180411 DATE AS OF CHANGE: 20180411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HURLY STEPHEN A CENTRAL INDEX KEY: 0001130637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 18750575 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 FIRST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_152348030962361.xml FORM 4 X0306 4 2018-04-09 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001130637 HURLY STEPHEN A C/O ELEVEN BIOTHERAPEUTICS, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 1.5 2018-04-09 4 A 0 250000 0 A 2028-04-08 Common Stock 250000.0 250000 D On April 9, 2018, the reporting person was awarded options to purchase 250,000 shares of common stock of Eleven Biotherapeutics, Inc. (the "Company"), which options vest 6.25% every three months over four years, provided the reporting person is employed by the Company on each such vesting date. /s/ Stephen A. Hurly 2018-04-11